MicrobiologybioRxivPreprint
Use of Stem Cell-Derived Cardiomyocyte and Nasal Epithelium Models to Establish a Multi-Tissue Model Platform to Validate Repurposed Drugs Against SARS-CoV-2 Infection
Nathan Gödde, Carmel O’Brien, Elizabeth Vincan…·Seshadri S. Vasan
The paper validates repurposed drugs against SARS-CoV-2 using stem cell-derived cardiomyocyte and nasal epithelium models, confirming fluvoxamine's antiviral efficacy in combination with other drugs.
DOI 10.1101/2024.05.22.595397